Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name ZN-A-1041
Trade Name
Synonyms ZN-A 1041|ZN-A1041
Drug Descriptions

ZN-A-1041 inhibits ERBB2 (HER2)-mediated downstream signaling, potentially resulting in tumor cell death (NCI Drug Dictionary).

DrugClasses HER2 Inhibitor 40
CAS Registry Number NA
NCIT ID C178299


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Ado-trastuzumab emtansine + ZN-A-1041 Ado-trastuzumab emtansine ZN-A-1041 0 1
Capecitabine + Trastuzumab + ZN-A-1041 Capecitabine Trastuzumab ZN-A-1041 0 0
Pertuzumab + Trastuzumab + ZN-A-1041 Pertuzumab Trastuzumab ZN-A-1041 0 1
Pertuzumab/trastuzumab/hyaluronidase-zzxf + ZN-A-1041 Pertuzumab/trastuzumab/hyaluronidase-zzxf ZN-A-1041 0 1
Trastuzumab deruxtecan + ZN-A-1041 Trastuzumab deruxtecan ZN-A-1041 0 1
ZN-A-1041 ZN-A-1041 0 1

Additional content available in CKB BOOST